메뉴 건너뛰기




Volumn 35, Issue 4, 2014, Pages 3793-3802

Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients

Author keywords

Colorectal cancer; Immunohistochemical staining; Matrix metalloproteinase 2; Tissue inhibitor of matrix metalloproteinases 2

Indexed keywords

GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

EID: 84899091125     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1502-8     Document Type: Article
Times cited : (58)

References (33)
  • 2
    • 0025312728 scopus 로고
    • A genetic model for colorectal tumorigenesis
    • 1:CAS:528:DyaK3cXktlyhtrg%3D 2188735 10.1016/0092-8674(90)90186-I
    • Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-67.
    • (1990) Cell , vol.61 , pp. 759-767
    • Fearon, E.R.1    Vogelstein, B.2
  • 3
    • 0037052641 scopus 로고    scopus 로고
    • Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
    • 1:CAS:528:DC%2BD38XivFyrsr4%3D 11979428 10.1002/ijc.10329
    • Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer. 2002;99:157-66.
    • (2002) Int J Cancer , vol.99 , pp. 157-166
    • Vihinen, P.1    Kahari, V.M.2
  • 4
    • 47549116029 scopus 로고    scopus 로고
    • Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer
    • 1:CAS:528:DC%2BD1cXmtFKqtr0%3D 18425389
    • Oshima T, Kunisaki C, Yoshihara K, et al. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer. Oncol Rep. 2008;19:1285-91.
    • (2008) Oncol Rep , vol.19 , pp. 1285-1291
    • Oshima, T.1    Kunisaki, C.2    Yoshihara, K.3
  • 5
    • 33747762613 scopus 로고    scopus 로고
    • Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease
    • 1:STN:280:DC%2BD28rhtV2mug%3D%3D 16650961 10.1016/j.ejso.2006.03.028
    • Waas ET, Wobbes T, Ruers T, Lomme RM, Hendriks T. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease. Eur J Surg Oncol. 2006;32:756-63.
    • (2006) Eur J Surg Oncol , vol.32 , pp. 756-763
    • Waas, E.T.1    Wobbes, T.2    Ruers, T.3    Lomme, R.M.4    Hendriks, T.5
  • 6
    • 77649210119 scopus 로고    scopus 로고
    • Expression of MMP-2, MMP-9 and collagen type IV and their relationship in colorectal carcinomas
    • 1:CAS:528:DC%2BD1MXhtlOmsrjO 18782525
    • Wu W, He JT, Ruan JD, Wang RB, Zhang YD. Expression of MMP-2, MMP-9 and collagen type IV and their relationship in colorectal carcinomas. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008;24:908-9.
    • (2008) Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. , vol.24 , pp. 908-909
    • Wu, W.1    He, J.T.2    Ruan, J.D.3    Wang, R.B.4    Zhang, Y.D.5
  • 7
    • 0035471778 scopus 로고    scopus 로고
    • Gelatinase B: A tuner and amplifier of immune functions
    • 1:CAS:528:DC%2BD3MXntV2nu7k%3D 11574282 10.1016/S1471-4906(01)02023-3
    • Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 2001;22:571-9.
    • (2001) Trends Immunol , vol.22 , pp. 571-579
    • Opdenakker, G.1    Van Den Steen, P.E.2    Van Damme, J.3
  • 8
    • 9944258056 scopus 로고    scopus 로고
    • The role of gelatinases in colorectal cancer progression and metastasis
    • 1:CAS:528:DC%2BD2cXhtVGgurvE 15588763
    • Mook OR, Frederiks WM, Van Noorden CJ. The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta. 2004;1705:69-89.
    • (2004) Biochim Biophys Acta , vol.1705 , pp. 69-89
    • Mook, O.R.1    Frederiks, W.M.2    Van Noorden, C.J.3
  • 9
    • 0242266487 scopus 로고    scopus 로고
    • Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
    • 1:CAS:528:DC%2BD3sXns1Cmur0%3D 2394290 14520459 10.1038/sj.bjc.6601238
    • Talvensaari-Mattila A, Paakko P, Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma. Br J Cancer. 2003;89:1270-75.
    • (2003) Br J Cancer , vol.89 , pp. 1270-1275
    • Talvensaari-Mattila, A.1    Paakko, P.2    Turpeenniemi-Hujanen, T.3
  • 10
    • 33748527496 scopus 로고    scopus 로고
    • Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer
    • 1:CAS:528:DC%2BD28Xptlaltbk%3D 2360506 16940985 10.1038/sj.bjc.6603307
    • Kubben FJ, Sier CF, Meijer MJ, et al. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer. 2006;95:744-51.
    • (2006) Br J Cancer , vol.95 , pp. 744-751
    • Kubben, F.J.1    Sier, C.F.2    Meijer, M.J.3
  • 11
    • 45949100633 scopus 로고    scopus 로고
    • The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters
    • 18630474
    • Giannopoulos G, Pavlakis K, Parasi A, et al. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters. Anticancer Res. 2008;28:1875-81.
    • (2008) Anticancer Res , vol.28 , pp. 1875-1881
    • Giannopoulos, G.1    Pavlakis, K.2    Parasi, A.3
  • 12
    • 72449145498 scopus 로고    scopus 로고
    • Active MMP-2 effectively identifies the presence of colorectal cancer
    • 1:CAS:528:DC%2BD1MXhtlSqsLjI 2775048 19551856 10.1002/ijc.24682
    • Murnane MJ, Cai J, Shuja S, McAneny D, Klepeis V, Willett JB. Active MMP-2 effectively identifies the presence of colorectal cancer. Int J Cancer. 2009;125:2893-902.
    • (2009) Int J Cancer , vol.125 , pp. 2893-2902
    • Murnane, M.J.1    Cai, J.2    Shuja, S.3    McAneny, D.4    Klepeis, V.5    Willett, J.B.6
  • 13
    • 20344407104 scopus 로고    scopus 로고
    • Matrix metalloproteinase-2 and tissue inhibitor of metallo-proteinase-2 in colorectal carcinoma invasion and metastasis
    • 1:CAS:528:DC%2BD2MXlvFKgt7k%3D 15918187
    • Li BH, Zhao P, Liu SZ, Yu YM, Han M, Wen JK. Matrix metalloproteinase-2 and tissue inhibitor of metallo-proteinase-2 in colorectal carcinoma invasion and metastasis. World J Gastroenterol. 2005;11:3046-50.
    • (2005) World J Gastroenterol , vol.11 , pp. 3046-3050
    • Li, B.H.1    Zhao, P.2    Liu, S.Z.3    Yu, Y.M.4    Han, M.5    Wen, J.K.6
  • 14
    • 79958069087 scopus 로고    scopus 로고
    • Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients
    • 21478099
    • Groblewska M, Mroczko B, Gryko M, Kȩdra B, Szmitkowski M. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients. Folia Histochem Cytobiol. 2010;48:564-71.
    • (2010) Folia Histochem Cytobiol , vol.48 , pp. 564-571
    • Groblewska, M.1    Mroczko, B.2    Gryko, M.3    Kȩdra, B.4    Szmitkowski, M.5
  • 15
    • 0003419489 scopus 로고
    • WHO International Histological Classification of Tumors Springer New York 10.1007/978-3-642-83693-0
    • Jass JR, Sobin LH, WHO International Histological Classification of Tumors. Histological typing of intestinal tumors. New York: Springer; 1989.
    • (1989) Histological Typing of Intestinal Tumors
    • Jass, J.R.1    Sobin, L.H.2
  • 16
    • 0030639658 scopus 로고    scopus 로고
    • Sampling variability of nonparametric estimates of the areas under receiver operating characteristic curves: An update
    • 1:STN:280:DyaK2s7ptlakug%3D%3D 9040870 10.1016/S1076-6332(97)80161-4
    • Hanley JA, Hajian-Tilaki KO. Sampling variability of nonparametric estimates of the areas under receiver operating characteristic curves: an update. Acad Radiol. 1997;4:49-58.
    • (1997) Acad Radiol , vol.4 , pp. 49-58
    • Hanley, J.A.1    Hajian-Tilaki, K.O.2
  • 17
    • 0022731304 scopus 로고
    • Algorithm 643. FEXACT: A FORTRAN subroutine for Fisher's exact test on unordered r×c contingency tables
    • 10.1145/6497.214326
    • Mehta CR, Patel NR. Algorithm 643. FEXACT: a FORTRAN subroutine for Fisher's exact test on unordered r×c contingency tables. TOMS. 1986;12:154-61.
    • (1986) TOMS , vol.12 , pp. 154-161
    • Mehta, C.R.1    Patel, N.R.2
  • 18
    • 0026515761 scopus 로고
    • Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells
    • 1:CAS:528:DyaK38XhvFWrt7w%3D 1311064
    • Sato H, Kida Y, Mai M, et al. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene. 1992;7:77-83.
    • (1992) Oncogene , vol.7 , pp. 77-83
    • Sato, H.1    Kida, Y.2    Mai, M.3
  • 19
    • 50649102546 scopus 로고    scopus 로고
    • Matrix metalloproteinases 2, 3, 13 and their type 2 tissue inhibitor in tumors and plasma of patients with colorectal cancer
    • 1:CAS:528:DC%2BD1cXhtVWnsb%2FI 19039945 10.1007/s10517-008-0092-8
    • Gershtein ES, Korotkova EA, Prorokov VV, Kushlinsky NE. Matrix metalloproteinases 2, 3, 13 and their type 2 tissue inhibitor in tumors and plasma of patients with colorectal cancer. Bull Exp Biol Med. 2008;145:362-6.
    • (2008) Bull Exp Biol Med , vol.145 , pp. 362-366
    • Gershtein, E.S.1    Korotkova, E.A.2    Prorokov, V.V.3    Kushlinsky, N.E.4
  • 20
    • 19444384982 scopus 로고    scopus 로고
    • Plasma levels of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 correlate with disease stage and survival in colorectal cancer patients
    • 15906450 10.1007/s10350-004-0854-y
    • Waas ET, Hendriks T, Lomme RM, Wobbes T. Plasma levels of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 correlate with disease stage and survival in colorectal cancer patients. Dis Colon Rectum. 2005;48:700-10.
    • (2005) Dis Colon Rectum , vol.48 , pp. 700-710
    • Waas, E.T.1    Hendriks, T.2    Lomme, R.M.3    Wobbes, T.4
  • 21
    • 0344002712 scopus 로고    scopus 로고
    • Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer
    • 1:CAS:528:DC%2BD3cXjtl2ku78%3D 10810401
    • Oberg A, Höyhtyä M, Tavelin B, Stenling R, Lindmark G. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Anticancer Res. 2000;20:1085-91.
    • (2000) Anticancer Res , vol.20 , pp. 1085-1091
    • Oberg, A.1    Höyhtyä, M.2    Tavelin, B.3    Stenling, R.4    Lindmark, G.5
  • 22
    • 34547102747 scopus 로고    scopus 로고
    • Matrix metalloproteinases in rectal mucosa, tumour and plasma: Response after preoperative irradiation
    • 17109104 10.1007/s00384-006-0225-3
    • Angenete E, Langenskiöld M, Falk P, Ivarsson ML. Matrix metalloproteinases in rectal mucosa, tumour and plasma: response after preoperative irradiation. Int J Colorectal Dis. 2007;22:667-74.
    • (2007) Int J Colorectal Dis. , vol.22 , pp. 667-674
    • Angenete, E.1    Langenskiöld, M.2    Falk, P.3    Ivarsson, M.L.4
  • 23
    • 17544372418 scopus 로고    scopus 로고
    • Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer
    • 15592677 10.1007/s00384-004-0667-4
    • Langenskiöld M, Holmdahl L, Falk P, Ivarsson ML. Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer. Int J Colorectal Dis. 2005;20:245-52.
    • (2005) Int J Colorectal Dis. , vol.20 , pp. 245-252
    • Langenskiöld, M.1    Holmdahl, L.2    Falk, P.3    Ivarsson, M.L.4
  • 24
    • 0032568932 scopus 로고    scopus 로고
    • TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads
    • 10.1074/jbc.273.26.16098
    • Kinoshita T, Sato H, Okada A, et al. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem. 1998;26:16098-103.
    • (1998) J Biol Chem , vol.26 , pp. 16098-16103
    • Kinoshita, T.1    Sato, H.2    Okada, A.3
  • 25
    • 0033597728 scopus 로고    scopus 로고
    • Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines
    • 10.1074/jbc.274.30.21056
    • Kurschat P, Zigrino P, Nischt R, et al. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J Biol Chem. 1999;23:21056-62.
    • (1999) J Biol Chem , vol.23 , pp. 21056-21062
    • Kurschat, P.1    Zigrino, P.2    Nischt, R.3
  • 26
    • 0030044480 scopus 로고    scopus 로고
    • Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer
    • 1:CAS:528:DyaK28Xit1CgsQ%3D%3D 8548762
    • Liabakk NB, Talbot I, Smith RA, Wilkinson K, Balkwill F. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 1996;56:190-6.
    • (1996) Cancer Res , vol.56 , pp. 190-196
    • Liabakk, N.B.1    Talbot, I.2    Smith, R.A.3    Wilkinson, K.4    Balkwill, F.5
  • 27
    • 33847145778 scopus 로고    scopus 로고
    • Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer
    • 1563482 16916471 10.1186/1471-2407-6-211
    • Kim TD, Song KS, Li G, et al. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. BMC Cancer. 2006;6:211-21.
    • (2006) BMC Cancer , vol.6 , pp. 211-221
    • Kim, T.D.1    Song, K.S.2    Li, G.3
  • 29
    • 24644461106 scopus 로고    scopus 로고
    • Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: Soluble tumor necrosis factor receptor type i - An independent prognostic factor
    • 1:CAS:528:DC%2BD2MXpvVSmsLg%3D 16006772 10.1159/000086951
    • Kaminska J, Nowacki MP, Kowalska M, et al. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I - an independent prognostic factor. Tumour Biol. 2005;26:186-94.
    • (2005) Tumour Biol , vol.26 , pp. 186-194
    • Kaminska, J.1    Nowacki, M.P.2    Kowalska, M.3
  • 30
    • 53849129529 scopus 로고    scopus 로고
    • Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients
    • 1:CAS:528:DC%2BD1cXhtlOqtrfE 18844497 10.1515/CCLM.2008.278
    • Groblewska M, Mroczko B, Wereszczyńska-Siemia̧tkowska U, et al. Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients. Clin Chem Lab Med. 2008;46:1423-8.
    • (2008) Clin Chem Lab Med , vol.46 , pp. 1423-1428
    • Groblewska, M.1    Mroczko, B.2    Wereszczyńska-Siemia̧tkowska, U.3
  • 31
    • 33845699864 scopus 로고    scopus 로고
    • Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer
    • 1:STN:280:DC%2BD28jjtFyisw%3D%3D 16896992 10.1007/s00384-006-0173-y
    • Schwandner O, Schlamp A, Broll R, Bruch HP. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer. Int J Colorectal Dis. 2007;22:127-36.
    • (2007) Int J Colorectal Dis. , vol.22 , pp. 127-136
    • Schwandner, O.1    Schlamp, A.2    Broll, R.3    Bruch, H.P.4
  • 32
    • 33748755463 scopus 로고    scopus 로고
    • The expression of matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs) and angiogenesis in relation to the depth of tumor invasion and lymph node metastasis in submucosally invasive colorectal carcinoma
    • 15973074
    • Jung SA, Yang SK, Kim JS, et al. The expression of matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs) and angiogenesis in relation to the depth of tumor invasion and lymph node metastasis in submucosally invasive colorectal carcinoma. Korean J Gastroenterol. 2005;45:401-8.
    • (2005) Korean J Gastroenterol , vol.45 , pp. 401-408
    • Jung, S.A.1    Yang, S.K.2    Kim, J.S.3
  • 33
    • 84860234041 scopus 로고    scopus 로고
    • MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients
    • 1:CAS:528:DC%2BC38Xmt1Ghurk%3D 3341861 22472880 10.1038/bjc.2012.80
    • Langers AM, Verspaget HW, Hawinkels LJ, et al. MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients. Br J Cancer. 2012;106:1495-8.
    • (2012) Br J Cancer , vol.106 , pp. 1495-1498
    • Langers, A.M.1    Verspaget, H.W.2    Hawinkels, L.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.